메뉴 건너뛰기




Volumn 139, Issue 2, 2003, Pages

Statin Use, Clinical Fracture, and Bone Density in Postmenopausal Women: Results from the Women's Health Initiative Observational Study

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTILIPEMIC AGENT; ATORVASTATIN; CORTICOSTEROID; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; PSYCHOTROPIC AGENT; SIMVASTATIN;

EID: 1642461391     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-2-200307150-00009     Document Type: Article
Times cited : (158)

References (22)
  • 1
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • PMID: 7968073
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-9. [PMID: 7968073]
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 2
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
    • PMID: 9613910
    • Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-22. [PMID: 9613910]
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3    Whitney, E.4    Shapiro, D.R.5    Beere, P.A.6
  • 3
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. [PMID: 9841303]
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349-57. [PMID: 9841303]
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 4
    • 0033596281 scopus 로고    scopus 로고
    • Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials
    • PMID: 10612322
    • LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA. 1999;282:2340-6. [PMID: 10612322]
    • (1999) JAMA , vol.282 , pp. 2340-2346
    • LaRosa, J.C.1    He, J.2    Vupputuri, S.3
  • 5
    • 0033521078 scopus 로고    scopus 로고
    • Stimulation of bone formation in vitro and in rodents by statins
    • PMID: 10583956
    • Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286:1946-9. [PMID: 10583956]
    • (1999) Science , vol.286 , pp. 1946-1999
    • Mundy, G.1    Garrett, R.2    Harris, S.3    Chan, J.4    Chen, D.5    Rossini, G.6
  • 7
    • 0034725352 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors and the risk of fractures
    • PMID: 10866867
    • Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA. 2000;283:3205-10. [PMID: 10866867]
    • (2000) JAMA , vol.283 , pp. 3205-3210
    • Meier, C.R.1    Schlienger, R.G.2    Kraenzlin, M.E.3    Schlegel, B.4    Jick, H.5
  • 8
    • 0034725357 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients
    • PMID: 10866868
    • Wang PS, Solomon DH, Mogun H, Avom J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA. 2000;283:3211-6. [PMID: 10866868]
    • (2000) JAMA , vol.283 , pp. 3211-3216
    • Wang, P.S.1    Solomon, D.H.2    Mogun, H.3    Avom, J.4
  • 9
    • 18544410718 scopus 로고    scopus 로고
    • Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
    • PMID: 10881890
    • Chan KA, Andrade SE, Boles M, Buist DS, Chase GA, Donahue JG, et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet. 2000;355:2185-8. [PMID: 10881890]
    • (2000) Lancet , vol.355 , pp. 2185-2188
    • Chan, K.A.1    Andrade, S.E.2    Boles, M.3    Buist, D.S.4    Chase, G.A.5    Donahue, J.G.6
  • 11
    • 0035901052 scopus 로고    scopus 로고
    • Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease
    • PMID: 11229669
    • Reid IR, Hague W, Emberson J, Baker J, Tonkin A, Hunt D, et al. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease. Lancet. 2001;357:509-12. [PMID: 11229669]
    • (2001) Lancet , vol.357 , pp. 509-512
    • Reid, I.R.1    Hague, W.2    Emberson, J.3    Baker, J.4    Tonkin, A.5    Hunt, D.6
  • 12
    • 0036190491 scopus 로고    scopus 로고
    • Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study
    • PMID: 11871921
    • Pasco JA, Kotowicz MA, Henry MJ, Sanders KM, Nicholson GC. Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study. Arch Intern Med. 2002;162:537-40. [PMID: 11871921]
    • (2002) Arch Intern Med , vol.162 , pp. 537-540
    • Pasco, J.A.1    Kotowicz, M.A.2    Henry, M.J.3    Sanders, K.M.4    Nicholson, G.C.5
  • 13
    • 6844255857 scopus 로고    scopus 로고
    • Design of the Women's Health Initiative clinical trial and observational study
    • The Women's Health Initiative Study Group. [PMID: 9492970]
    • Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998;19:61-109. [PMID: 9492970]
    • (1998) Control Clin Trials , vol.19 , pp. 61-109
  • 14
    • 0032032592 scopus 로고    scopus 로고
    • Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
    • PMID: 9514454
    • Jones P, Kafonek S, Laurora I, Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol. 1998;81:582-7. [PMID: 9514454]
    • (1998) Am J Cardiol , vol.81 , pp. 582-587
    • Jones, P.1    Kafonek, S.2    Laurora, I.3    Hunninghake, D.4
  • 15
    • 0030703119 scopus 로고    scopus 로고
    • Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: The Women's Health Trial Feasibility Study in Minority Populations
    • PMID: 9384206
    • Kristal AR, Feng Z, Coates RJ, Oberman A, George V. Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations. Am J Epidemiol. 1997;146:856-69. [PMID: 9384206]
    • (1997) Am J Epidemiol. , vol.146 , pp. 856-869
    • Kristal, A.R.1    Feng, Z.2    Coates, R.J.3    Oberman, A.4    George, V.5
  • 16
    • 0026877917 scopus 로고
    • The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
    • PMID: 1593914
    • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-83. [PMID: 1593914]
    • (1992) Med Care , vol.30 , pp. 473-483
    • Ware Jr., J.E.1    Sherbourne, C.D.2
  • 17
    • 0031660868 scopus 로고    scopus 로고
    • Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults
    • PMID: 9771869
    • Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr. 1998;68:899-917. [PMID: 9771869]
    • (1998) Am J Clin Nutr , vol.68 , pp. 899-917
  • 19
    • 0000795922 scopus 로고    scopus 로고
    • Statins mediate their effects on osteoblasts by inhibition of HMG-CoA reductase and ultimately BMP-2
    • Garrett IR, Esparza J, Chen D, Zhao M, Gutierrez G, Escobedo A, et al. Statins mediate their effects on osteoblasts by inhibition of HMG-CoA reductase and ultimately BMP-2 [Abstract]. J Bone Miner Res. 2000;15(Suppl):S225.
    • (2000) J Bone Miner Res , vol.15 , Issue.SUPPL.
    • Garrett, I.R.1    Esparza, J.2    Chen, D.3    Zhao, M.4    Gutierrez, G.5    Escobedo, A.6
  • 20
    • 0034454445 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients
    • PMID: 10720052
    • Chung YS, Lee MD, Lee SK, Kim HM, Fitzpatrick LA. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab. 2000;85:1137-42. [PMID: 10720052]
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 1137-1142
    • Chung, Y.S.1    Lee, M.D.2    Lee, S.K.3    Kim, H.M.4    Fitzpatrick, L.A.5
  • 21
    • 0034709764 scopus 로고    scopus 로고
    • Oral statins and increased bone-mineral density in postmenopausal women
    • PMID: 10881898
    • Edwards CJ, Hart DJ, Spector TD. Oral statins and increased bone-mineral density in postmenopausal women [Letter]. Lancet. 2000;355:2218-9. [PMID: 10881898]
    • (2000) Lancet , vol.355 , pp. 2218-2219
    • Edwards, C.J.1    Hart, D.J.2    Spector, T.D.3
  • 22
    • 0000901664 scopus 로고    scopus 로고
    • Effects of one year treatment with statins on bone mass and metabolism
    • Watanabe S, Fukumoto S, Takeuchi Y, Nakano T, Fujita T. Effects of one year treatment with statins on bone mass and metabolism [Abstract]. J Bone Miner Res. 2000;15(Suppl):S194.
    • (2000) J Bone Miner Res , vol.15 , Issue.SUPPL.
    • Watanabe, S.1    Fukumoto, S.2    Takeuchi, Y.3    Nakano, T.4    Fujita, T.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.